ING Group’s Genomic Health, Inc. GHDX Stock Holding History

ING Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-40,593	Closed	-$1.19M	–	769
2013 Q4	$1.19M	Sell	40,593 -4,479	-10%	-$142K	0.01%	538
2013 Q3	$1.37M	Hold	45,072	–	–	0.01%	534
2013 Q2	$1.44M	Buy	+45,072	New	+$1.48M	0.01%	508

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

ICM

IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

ING Group's GHDX Position: Q1 2014 in Review

ING Group sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 40,593 shares — an estimated $1.19M sold.

ING Group first reported a position in GHDX in Q2 2013 and held it in 3 quarters. The position peaked at $1.44M in Q2 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

ING Group reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
ING Group sold 40,593 Genomic Health, Inc. shares in Q1 2014, an estimated $1.19M.
ING Group first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 3 quarters.
ING Group's Genomic Health, Inc. position peaked at $1.44M in Q2 2013.
101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on ING Group's 13F filing for Q1 2014, filed 14 May 2014.